Tulane University School of Medicine
Assistant Professor, Department of Pharmacology
Dr. Hamblin’s research investigates sex-related differences in the role of estrogen receptors in vascular biology and pathophysiology, including conditions linking cardiovascular diseases and diabetes. Specifically, the long-term objectives of our laboratory are to gain a better understanding of sex-specific differences in estrogen receptor signaling in vascular remodeling diseases, with an emphasis on diabetic complications associated with atherosclerosis and vascular occlusion. These studies are expected to provide insight into the critical importance of sex-specific nuclear and extranuclear estrogen receptor signaling in vascular diseases and the complications of diabetes.
Dr. Hamblin received his A.B. degree from Dartmouth College and later received an M.A. in Medical Sciences from Boston University and his Ph.D. in Biomedical Sciences from Meharry Medical College. Dr. Hamblin completed his postdoctoral fellowship in the Department of Internal Medicine, Cardiology Division at the University of Michigan.
Sex-specific estrogen receptor signaling during cardiovascular complications of diabetes
Habib Ansari, PhD
Tulane BIRCWH: http://tulane.edu/publichealth/bircwh/home_bircwh.cfm
1430 Tulane Ave, New Orleans, LA 70112 504-988-5251 email@example.com